Additionally, CBSA announced several newly appointed and reappointed board members. They are as follows:
Newly appointed CBSA board members include:
Brenda Fielding, executive vice president of regulatory and strategic development for Clinipace;
Scott Larson, senior vice president and legal and general counsel for Lakewood-based Terumo BCT;
Brett Lund, executive vice president, general counsel and secretary of Englewood-based Gevo; Bill Marshall, Ph.D., president, CEO, co-founder and director of Boulder-based miRagen; Chris Myatt, Ph.D., co-founder and CEO of Boulder-based MBio Diagnostics Inc.; Bob Reddy, director of global marketing for Medtronic.
Reappointments of CBSA board members include:
Derek Cole, president of Investor Relations Advisory Solutions; Betty Iverson, director of state government affairs for Johnson & Johnson;
Kevin Smith, president and CEO of Aurora-based CID4; Rick Silva, senior director of technology transfer for the University of Colorado-Denver; Sean Moriarty, vice president and general counsel for Fort Collins-based TOLMAR Inc.; Bruce Eaton, president and CEO of i2 Pharmaceuticals Inc.